GliaPharm is a Swiss-based biotechnology company that develops treatments for neurological and psychiatric disorders.
GliaPharm's innovative therapeutic approach is to target glial cells, the 'support cells' of neurons, to sustain and enhance brain metabolism in pathological conditions. Our vision is to become a leading biotechnology company with a focus on glia-mediated pathways as agents for neuroprotection and maintenance of cognitive functions.
Company Details
- Employees
- 9
- Founded
- -
- Address
- Campus Biotech, Chemin Des Mines 9,switzerland
- Phone
- 41 22 545 11 15
- in****@****arm.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- gliapharm.com
- Keywords
- iOnctura.
- HQ
- Geneva, Geneva
Gliapharm Sa Questions
Gliapharm Sa's helpline number is 41 22 545 11 15
Gliapharm Sa's website is gliapharm.com
Gliapharm Sa's LinkedIn profile is https://ch.linkedin.com/company/gliapharm
Gliapharm Sa has
9 employees.
View email and phone details for 9
employees at Gliapharm Sa.
Gliapharm Sa's industry is
Biotechnology Research
Gliapharm Sa's top competitors are
Light Chain Bioscience | Novimmune Sa,
Addex Therapeutics,
Amal Therapeutics,
Ionctura,
Neurix Sa,
Adc Therapeutics,
Powerapi,
Alithea Genomics,
Selexis Sa,
Geneuro Sa.
Gliapharm Sa's support email address is info@gliapharm.com
Gliapharm Sa's categories are Biotechnology Research
Gliapharm Sa's founding year is 2016
